Search results
Results From The WOW.Com Content Network
Oxford University Innovation files, on average, one patent application each week, manages over 360 patent application families and has concluded over 450 licence agreements which has made Oxford University Innovation "one of the country's most prolific technology transfer offices when it comes to agreeing licensing deals". [9]
Oxford Science Enterprises (OSE) (Previously known as Oxford Sciences Innovation) is a British early-stage venture capital firm with over $800M in AUM based in Oxford, UK. [1] [2] It operates in partnership with the University of Oxford, as the university's preferred investor, several prominent financiers back the firm, including Google Ventures, Sequoia Capital, Tencent, Huawei and Invesco.
The Oxford Robotics Institute (ORI) is an interdisciplinary division within the University of Oxford. It is dedicated to researching robotics, artificial intelligence, systems engineering, and other related fields.
The MRC Weatherall Institute of Molecular Medicine at the University of Oxford [1] is a research institute located at the John Radcliffe Hospital in Oxford. Founded in 1989 by Sir David Weatherall, the institute focuses on furthering our understanding of clinical medicine at a molecular level.
IPC tied up with Oxford Research in 1996 which was the first step in the rebranding of the company. But it was first in 2005 when the company moved its headquarters to Oxford, England, that the company changed its name to Oxford Leadership Academy. [5] The company have served a wide array of large-scale corporations.
The Ineos Oxford Institute for Antimicrobial Research (IOI) [1] is a multidisciplinary research institute at the University of Oxford. The IOI was established in January 2021 thanks to a £100m donation from INEOS, one of the world's largest manufacturing companies.
Oxbotica has raised over $18 million to date and is backed by the IP Group, Parkwalk Advisors and AXA XL. [5] In 2018, Uber's former Head of Business EMEA Fraser Robinson was appointed to the board of directors. [6] In May 2019, Ozgur Tohumcu replaced Dr Graeme Smith as Oxbotica's CEO. [7] Also in 2019, the company opened an office in Toronto ...
The core of the Scientific Advice Mechanism is the European Commission's Group of Chief Scientific Advisors, an expert group consisting of up to seven leading scientists, selected by the European Commission assisted by an independent identification committee.